nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—CYP3A4—Temozolomide—melanoma	0.153	0.576	CbGbCtD
Guanfacine—CYP3A4—Vemurafenib—melanoma	0.0841	0.316	CbGbCtD
Guanfacine—CYP3A4—Docetaxel—melanoma	0.0288	0.108	CbGbCtD
Guanfacine—NISCH—Paclitaxel—Docetaxel—melanoma	0.0262	1	CbGdCrCtD
Guanfacine—Diclofenac—CXCR1—melanoma	0.0197	0.688	CrCbGaD
Guanfacine—Paresis—Temozolomide—melanoma	0.0132	0.0294	CcSEcCtD
Guanfacine—Hypokinesia—Carmustine—melanoma	0.00739	0.0165	CcSEcCtD
Guanfacine—Pain in extremity—Vemurafenib—melanoma	0.00685	0.0153	CcSEcCtD
Guanfacine—Skin exfoliation—Bleomycin—melanoma	0.00546	0.0122	CcSEcCtD
Guanfacine—Diclofenac—CXCL8—melanoma	0.00497	0.174	CrCbGaD
Guanfacine—Urinary incontinence—Carmustine—melanoma	0.00482	0.0107	CcSEcCtD
Guanfacine—Skin exfoliation—Carmustine—melanoma	0.00477	0.0106	CcSEcCtD
Guanfacine—Urinary incontinence—Temozolomide—melanoma	0.00466	0.0104	CcSEcCtD
Guanfacine—Skin exfoliation—Temozolomide—melanoma	0.0046	0.0103	CcSEcCtD
Guanfacine—Eye disorder—Vemurafenib—melanoma	0.00443	0.00986	CcSEcCtD
Guanfacine—Cerebrovascular accident—Bleomycin—melanoma	0.00424	0.00943	CcSEcCtD
Guanfacine—Alopecia—Vemurafenib—melanoma	0.00419	0.00933	CcSEcCtD
Guanfacine—Dysgeusia—Vemurafenib—melanoma	0.00404	0.009	CcSEcCtD
Guanfacine—Lethargy—Dactinomycin—melanoma	0.00395	0.0088	CcSEcCtD
Guanfacine—Vascular purpura—Temozolomide—melanoma	0.00391	0.00872	CcSEcCtD
Guanfacine—Amnesia—Carmustine—melanoma	0.00386	0.00859	CcSEcCtD
Guanfacine—Amnesia—Temozolomide—melanoma	0.00373	0.0083	CcSEcCtD
Guanfacine—Dermatitis exfoliative—Temozolomide—melanoma	0.00371	0.00826	CcSEcCtD
Guanfacine—Purpura—Temozolomide—melanoma	0.00363	0.00809	CcSEcCtD
Guanfacine—Liver function test abnormal—Dactinomycin—melanoma	0.00357	0.00796	CcSEcCtD
Guanfacine—Arthralgia—Vemurafenib—melanoma	0.00351	0.00782	CcSEcCtD
Guanfacine—Myalgia—Vemurafenib—melanoma	0.00351	0.00782	CcSEcCtD
Guanfacine—Affect lability—Temozolomide—melanoma	0.00345	0.00767	CcSEcCtD
Guanfacine—Dysphagia—Dactinomycin—melanoma	0.00335	0.00745	CcSEcCtD
Guanfacine—Liver function test abnormal—Carmustine—melanoma	0.00334	0.00745	CcSEcCtD
Guanfacine—Acute coronary syndrome—Bleomycin—melanoma	0.00315	0.00702	CcSEcCtD
Guanfacine—Hypotension—Vemurafenib—melanoma	0.00315	0.00701	CcSEcCtD
Guanfacine—Myocardial infarction—Bleomycin—melanoma	0.00314	0.00698	CcSEcCtD
Guanfacine—Dysphagia—Carmustine—melanoma	0.00313	0.00697	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Temozolomide—melanoma	0.00309	0.00688	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00307	0.00683	CcSEcCtD
Guanfacine—Skin exfoliation—Docetaxel—melanoma	0.00306	0.00682	CcSEcCtD
Guanfacine—Dysphagia—Temozolomide—melanoma	0.00303	0.00674	CcSEcCtD
Guanfacine—Decreased appetite—Vemurafenib—melanoma	0.00293	0.00652	CcSEcCtD
Guanfacine—Fatigue—Vemurafenib—melanoma	0.0029	0.00646	CcSEcCtD
Guanfacine—Constipation—Vemurafenib—melanoma	0.00288	0.00641	CcSEcCtD
Guanfacine—Pollakiuria—Temozolomide—melanoma	0.0028	0.00622	CcSEcCtD
Guanfacine—Erectile dysfunction—Temozolomide—melanoma	0.00279	0.00621	CcSEcCtD
Guanfacine—Weight increased—Temozolomide—melanoma	0.00275	0.00613	CcSEcCtD
Guanfacine—Cardiac failure congestive—Docetaxel—melanoma	0.00257	0.00572	CcSEcCtD
Guanfacine—Alopecia—Bleomycin—melanoma	0.00254	0.00565	CcSEcCtD
Guanfacine—Hallucination—Carmustine—melanoma	0.00249	0.00555	CcSEcCtD
Guanfacine—Hypersensitivity—Vemurafenib—melanoma	0.00248	0.00552	CcSEcCtD
Guanfacine—Asthenia—Vemurafenib—melanoma	0.00242	0.00538	CcSEcCtD
Guanfacine—Visual impairment—Carmustine—melanoma	0.00242	0.00538	CcSEcCtD
Guanfacine—Hallucination—Temozolomide—melanoma	0.00241	0.00537	CcSEcCtD
Guanfacine—Pruritus—Vemurafenib—melanoma	0.00238	0.0053	CcSEcCtD
Guanfacine—Lethargy—Docetaxel—melanoma	0.00238	0.00529	CcSEcCtD
Guanfacine—Alopecia—Dactinomycin—melanoma	0.00237	0.00527	CcSEcCtD
Guanfacine—Eye disorder—Carmustine—melanoma	0.00234	0.00522	CcSEcCtD
Guanfacine—Visual impairment—Temozolomide—melanoma	0.00233	0.0052	CcSEcCtD
Guanfacine—Pain in extremity—Docetaxel—melanoma	0.00233	0.00518	CcSEcCtD
Guanfacine—Ill-defined disorder—Bleomycin—melanoma	0.00232	0.00516	CcSEcCtD
Guanfacine—Diarrhoea—Vemurafenib—melanoma	0.0023	0.00513	CcSEcCtD
Guanfacine—Eye disorder—Temozolomide—melanoma	0.00226	0.00504	CcSEcCtD
Guanfacine—Tinnitus—Temozolomide—melanoma	0.00226	0.00503	CcSEcCtD
Guanfacine—Malaise—Bleomycin—melanoma	0.00225	0.00502	CcSEcCtD
Guanfacine—Dizziness—Vemurafenib—melanoma	0.00223	0.00496	CcSEcCtD
Guanfacine—Alopecia—Carmustine—melanoma	0.00221	0.00493	CcSEcCtD
Guanfacine—Immune system disorder—Temozolomide—melanoma	0.00219	0.00487	CcSEcCtD
Guanfacine—Ill-defined disorder—Dactinomycin—melanoma	0.00216	0.00482	CcSEcCtD
Guanfacine—Liver function test abnormal—Docetaxel—melanoma	0.00215	0.00479	CcSEcCtD
Guanfacine—Vomiting—Vemurafenib—melanoma	0.00214	0.00477	CcSEcCtD
Guanfacine—Alopecia—Temozolomide—melanoma	0.00214	0.00477	CcSEcCtD
Guanfacine—Chest pain—Bleomycin—melanoma	0.00213	0.00474	CcSEcCtD
Guanfacine—Myalgia—Bleomycin—melanoma	0.00213	0.00474	CcSEcCtD
Guanfacine—Abdominal pain upper—Docetaxel—melanoma	0.00213	0.00474	CcSEcCtD
Guanfacine—Orthostatic hypotension—Docetaxel—melanoma	0.00213	0.00474	CcSEcCtD
Guanfacine—Rash—Vemurafenib—melanoma	0.00212	0.00473	CcSEcCtD
Guanfacine—Dermatitis—Vemurafenib—melanoma	0.00212	0.00472	CcSEcCtD
Guanfacine—Headache—Vemurafenib—melanoma	0.00211	0.0047	CcSEcCtD
Guanfacine—Discomfort—Bleomycin—melanoma	0.0021	0.00468	CcSEcCtD
Guanfacine—Malaise—Dactinomycin—melanoma	0.0021	0.00468	CcSEcCtD
Guanfacine—Dysgeusia—Temozolomide—melanoma	0.00206	0.0046	CcSEcCtD
Guanfacine—Confusional state—Bleomycin—melanoma	0.00206	0.00458	CcSEcCtD
Guanfacine—Vision blurred—Carmustine—melanoma	0.00206	0.00458	CcSEcCtD
Guanfacine—Alanine aminotransferase increased—Docetaxel—melanoma	0.00205	0.00457	CcSEcCtD
Guanfacine—Tremor—Carmustine—melanoma	0.00204	0.00455	CcSEcCtD
Guanfacine—Oedema—Bleomycin—melanoma	0.00204	0.00454	CcSEcCtD
Guanfacine—Dysphagia—Docetaxel—melanoma	0.00201	0.00448	CcSEcCtD
Guanfacine—Agitation—Carmustine—melanoma	0.00201	0.00446	CcSEcCtD
Guanfacine—Nausea—Vemurafenib—melanoma	0.002	0.00445	CcSEcCtD
Guanfacine—Vision blurred—Temozolomide—melanoma	0.00199	0.00442	CcSEcCtD
Guanfacine—Myalgia—Dactinomycin—melanoma	0.00198	0.00442	CcSEcCtD
Guanfacine—Tremor—Temozolomide—melanoma	0.00198	0.0044	CcSEcCtD
Guanfacine—Discomfort—Dactinomycin—melanoma	0.00196	0.00437	CcSEcCtD
Guanfacine—Ill-defined disorder—Temozolomide—melanoma	0.00196	0.00436	CcSEcCtD
Guanfacine—Agitation—Temozolomide—melanoma	0.00194	0.00431	CcSEcCtD
Guanfacine—Hypotension—Bleomycin—melanoma	0.00191	0.00424	CcSEcCtD
Guanfacine—Oedema—Dactinomycin—melanoma	0.0019	0.00424	CcSEcCtD
Guanfacine—Malaise—Temozolomide—melanoma	0.0019	0.00423	CcSEcCtD
Guanfacine—Vertigo—Temozolomide—melanoma	0.00189	0.00422	CcSEcCtD
Guanfacine—Convulsion—Carmustine—melanoma	0.00189	0.00421	CcSEcCtD
Guanfacine—Hypertension—Carmustine—melanoma	0.00188	0.00419	CcSEcCtD
Guanfacine—Palpitations—Temozolomide—melanoma	0.00186	0.00415	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Bleomycin—melanoma	0.00186	0.00414	CcSEcCtD
Guanfacine—Myalgia—Carmustine—melanoma	0.00186	0.00414	CcSEcCtD
Guanfacine—Chest pain—Carmustine—melanoma	0.00186	0.00414	CcSEcCtD
Guanfacine—Anxiety—Carmustine—melanoma	0.00185	0.00412	CcSEcCtD
Guanfacine—Paraesthesia—Bleomycin—melanoma	0.00183	0.00408	CcSEcCtD
Guanfacine—Weight increased—Docetaxel—melanoma	0.00183	0.00408	CcSEcCtD
Guanfacine—Convulsion—Temozolomide—melanoma	0.00183	0.00407	CcSEcCtD
Guanfacine—Hypertension—Temozolomide—melanoma	0.00182	0.00405	CcSEcCtD
Guanfacine—Dyspnoea—Bleomycin—melanoma	0.00182	0.00405	CcSEcCtD
Guanfacine—Confusional state—Carmustine—melanoma	0.0018	0.004	CcSEcCtD
Guanfacine—Arthralgia—Temozolomide—melanoma	0.0018	0.004	CcSEcCtD
Guanfacine—Myalgia—Temozolomide—melanoma	0.0018	0.004	CcSEcCtD
Guanfacine—Anxiety—Temozolomide—melanoma	0.00179	0.00398	CcSEcCtD
Guanfacine—Oedema—Carmustine—melanoma	0.00178	0.00397	CcSEcCtD
Guanfacine—Discomfort—Temozolomide—melanoma	0.00177	0.00395	CcSEcCtD
Guanfacine—Decreased appetite—Bleomycin—melanoma	0.00177	0.00395	CcSEcCtD
Guanfacine—Acute coronary syndrome—Docetaxel—melanoma	0.00177	0.00394	CcSEcCtD
Guanfacine—Myocardial infarction—Docetaxel—melanoma	0.00176	0.00392	CcSEcCtD
Guanfacine—Dry mouth—Temozolomide—melanoma	0.00176	0.00391	CcSEcCtD
Guanfacine—Conjunctivitis—Docetaxel—melanoma	0.00174	0.00388	CcSEcCtD
Guanfacine—Tachycardia—Carmustine—melanoma	0.00174	0.00387	CcSEcCtD
Guanfacine—Confusional state—Temozolomide—melanoma	0.00174	0.00386	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00173	0.00386	CcSEcCtD
Guanfacine—Oedema—Temozolomide—melanoma	0.00172	0.00383	CcSEcCtD
Guanfacine—Feeling abnormal—Bleomycin—melanoma	0.00168	0.00374	CcSEcCtD
Guanfacine—Hypotension—Carmustine—melanoma	0.00166	0.00371	CcSEcCtD
Guanfacine—Hyperhidrosis—Temozolomide—melanoma	0.00166	0.0037	CcSEcCtD
Guanfacine—Decreased appetite—Dactinomycin—melanoma	0.00165	0.00368	CcSEcCtD
Guanfacine—Fatigue—Dactinomycin—melanoma	0.00164	0.00365	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Carmustine—melanoma	0.00162	0.00361	CcSEcCtD
Guanfacine—Rhinitis—Docetaxel—melanoma	0.00161	0.0036	CcSEcCtD
Guanfacine—Insomnia—Carmustine—melanoma	0.00161	0.00359	CcSEcCtD
Guanfacine—Paraesthesia—Carmustine—melanoma	0.0016	0.00356	CcSEcCtD
Guanfacine—Dyspnoea—Carmustine—melanoma	0.00159	0.00354	CcSEcCtD
Guanfacine—Somnolence—Carmustine—melanoma	0.00158	0.00352	CcSEcCtD
Guanfacine—Feeling abnormal—Dactinomycin—melanoma	0.00157	0.00349	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00157	0.00349	CcSEcCtD
Guanfacine—Insomnia—Temozolomide—melanoma	0.00156	0.00347	CcSEcCtD
Guanfacine—Gastrointestinal pain—Dactinomycin—melanoma	0.00156	0.00346	CcSEcCtD
Guanfacine—Visual impairment—Docetaxel—melanoma	0.00155	0.00346	CcSEcCtD
Guanfacine—Decreased appetite—Carmustine—melanoma	0.00155	0.00345	CcSEcCtD
Guanfacine—Paraesthesia—Temozolomide—melanoma	0.00155	0.00344	CcSEcCtD
Guanfacine—Dyspnoea—Temozolomide—melanoma	0.00153	0.00342	CcSEcCtD
Guanfacine—Somnolence—Temozolomide—melanoma	0.00153	0.00341	CcSEcCtD
Guanfacine—Constipation—Carmustine—melanoma	0.00152	0.00339	CcSEcCtD
Guanfacine—Dyspepsia—Temozolomide—melanoma	0.00151	0.00337	CcSEcCtD
Guanfacine—Eye disorder—Docetaxel—melanoma	0.00151	0.00335	CcSEcCtD
Guanfacine—Abdominal pain—Dactinomycin—melanoma	0.0015	0.00335	CcSEcCtD
Guanfacine—Hypersensitivity—Bleomycin—melanoma	0.0015	0.00335	CcSEcCtD
Guanfacine—Decreased appetite—Temozolomide—melanoma	0.0015	0.00333	CcSEcCtD
Guanfacine—Fatigue—Temozolomide—melanoma	0.00148	0.0033	CcSEcCtD
Guanfacine—Constipation—Temozolomide—melanoma	0.00147	0.00328	CcSEcCtD
Guanfacine—Feeling abnormal—Carmustine—melanoma	0.00147	0.00327	CcSEcCtD
Guanfacine—Asthenia—Bleomycin—melanoma	0.00146	0.00326	CcSEcCtD
Guanfacine—Gastrointestinal pain—Carmustine—melanoma	0.00146	0.00324	CcSEcCtD
Guanfacine—Immune system disorder—Docetaxel—melanoma	0.00145	0.00324	CcSEcCtD
Guanfacine—Diclofenac—PTGS2—melanoma	0.00145	0.0506	CrCbGaD
Guanfacine—Pruritus—Bleomycin—melanoma	0.00144	0.00321	CcSEcCtD
Guanfacine—Alopecia—Docetaxel—melanoma	0.00142	0.00317	CcSEcCtD
Guanfacine—Feeling abnormal—Temozolomide—melanoma	0.00142	0.00316	CcSEcCtD
Guanfacine—Abdominal pain—Carmustine—melanoma	0.00141	0.00313	CcSEcCtD
Guanfacine—Gastrointestinal pain—Temozolomide—melanoma	0.00141	0.00313	CcSEcCtD
Guanfacine—Hypersensitivity—Dactinomycin—melanoma	0.0014	0.00312	CcSEcCtD
Guanfacine—Dysgeusia—Docetaxel—melanoma	0.00137	0.00306	CcSEcCtD
Guanfacine—Asthenia—Dactinomycin—melanoma	0.00137	0.00304	CcSEcCtD
Guanfacine—Abdominal pain—Temozolomide—melanoma	0.00136	0.00303	CcSEcCtD
Guanfacine—Muscle spasms—Docetaxel—melanoma	0.00135	0.003	CcSEcCtD
Guanfacine—Hypersensitivity—Carmustine—melanoma	0.00131	0.00292	CcSEcCtD
Guanfacine—Diarrhoea—Dactinomycin—melanoma	0.0013	0.0029	CcSEcCtD
Guanfacine—Vomiting—Bleomycin—melanoma	0.0013	0.00289	CcSEcCtD
Guanfacine—Diclofenac—ALB—melanoma	0.00129	0.0451	CrCbGaD
Guanfacine—Rash—Bleomycin—melanoma	0.00129	0.00286	CcSEcCtD
Guanfacine—Dermatitis—Bleomycin—melanoma	0.00129	0.00286	CcSEcCtD
Guanfacine—Asthenia—Carmustine—melanoma	0.00128	0.00284	CcSEcCtD
Guanfacine—Hypersensitivity—Temozolomide—melanoma	0.00127	0.00282	CcSEcCtD
Guanfacine—Syncope—Docetaxel—melanoma	0.00126	0.0028	CcSEcCtD
Guanfacine—Palpitations—Docetaxel—melanoma	0.00124	0.00276	CcSEcCtD
Guanfacine—Asthenia—Temozolomide—melanoma	0.00123	0.00275	CcSEcCtD
Guanfacine—Diclofenac—ABCB1—melanoma	0.00123	0.043	CrCbGaD
Guanfacine—Loss of consciousness—Docetaxel—melanoma	0.00123	0.00274	CcSEcCtD
Guanfacine—Diarrhoea—Carmustine—melanoma	0.00122	0.00271	CcSEcCtD
Guanfacine—Pruritus—Temozolomide—melanoma	0.00122	0.00271	CcSEcCtD
Guanfacine—Convulsion—Docetaxel—melanoma	0.00121	0.00271	CcSEcCtD
Guanfacine—Nausea—Bleomycin—melanoma	0.00121	0.0027	CcSEcCtD
Guanfacine—Hypertension—Docetaxel—melanoma	0.00121	0.0027	CcSEcCtD
Guanfacine—Vomiting—Dactinomycin—melanoma	0.00121	0.00269	CcSEcCtD
Guanfacine—Rash—Dactinomycin—melanoma	0.0012	0.00267	CcSEcCtD
Guanfacine—Chest pain—Docetaxel—melanoma	0.00119	0.00266	CcSEcCtD
Guanfacine—Arthralgia—Docetaxel—melanoma	0.00119	0.00266	CcSEcCtD
Guanfacine—Myalgia—Docetaxel—melanoma	0.00119	0.00266	CcSEcCtD
Guanfacine—Dizziness—Carmustine—melanoma	0.00118	0.00262	CcSEcCtD
Guanfacine—Diarrhoea—Temozolomide—melanoma	0.00118	0.00262	CcSEcCtD
Guanfacine—Dry mouth—Docetaxel—melanoma	0.00117	0.0026	CcSEcCtD
Guanfacine—Confusional state—Docetaxel—melanoma	0.00115	0.00257	CcSEcCtD
Guanfacine—Oedema—Docetaxel—melanoma	0.00114	0.00255	CcSEcCtD
Guanfacine—Dizziness—Temozolomide—melanoma	0.00114	0.00253	CcSEcCtD
Guanfacine—Vomiting—Carmustine—melanoma	0.00113	0.00252	CcSEcCtD
Guanfacine—Nausea—Dactinomycin—melanoma	0.00113	0.00252	CcSEcCtD
Guanfacine—Shock—Docetaxel—melanoma	0.00113	0.00251	CcSEcCtD
Guanfacine—Rash—Carmustine—melanoma	0.00112	0.0025	CcSEcCtD
Guanfacine—Dermatitis—Carmustine—melanoma	0.00112	0.0025	CcSEcCtD
Guanfacine—Tachycardia—Docetaxel—melanoma	0.00112	0.00249	CcSEcCtD
Guanfacine—Headache—Carmustine—melanoma	0.00112	0.00248	CcSEcCtD
Guanfacine—Vomiting—Temozolomide—melanoma	0.00109	0.00244	CcSEcCtD
Guanfacine—Rash—Temozolomide—melanoma	0.00109	0.00242	CcSEcCtD
Guanfacine—Dermatitis—Temozolomide—melanoma	0.00108	0.00241	CcSEcCtD
Guanfacine—Headache—Temozolomide—melanoma	0.00108	0.0024	CcSEcCtD
Guanfacine—Hypotension—Docetaxel—melanoma	0.00107	0.00238	CcSEcCtD
Guanfacine—Nausea—Carmustine—melanoma	0.00106	0.00236	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00104	0.00232	CcSEcCtD
Guanfacine—Insomnia—Docetaxel—melanoma	0.00104	0.0023	CcSEcCtD
Guanfacine—Paraesthesia—Docetaxel—melanoma	0.00103	0.00229	CcSEcCtD
Guanfacine—Nausea—Temozolomide—melanoma	0.00102	0.00228	CcSEcCtD
Guanfacine—Dyspnoea—Docetaxel—melanoma	0.00102	0.00227	CcSEcCtD
Guanfacine—Somnolence—Docetaxel—melanoma	0.00102	0.00227	CcSEcCtD
Guanfacine—Dyspepsia—Docetaxel—melanoma	0.00101	0.00224	CcSEcCtD
Guanfacine—Decreased appetite—Docetaxel—melanoma	0.000995	0.00222	CcSEcCtD
Guanfacine—Fatigue—Docetaxel—melanoma	0.000987	0.0022	CcSEcCtD
Guanfacine—Constipation—Docetaxel—melanoma	0.000979	0.00218	CcSEcCtD
Guanfacine—Feeling abnormal—Docetaxel—melanoma	0.000943	0.0021	CcSEcCtD
Guanfacine—Gastrointestinal pain—Docetaxel—melanoma	0.000936	0.00208	CcSEcCtD
Guanfacine—Abdominal pain—Docetaxel—melanoma	0.000905	0.00201	CcSEcCtD
Guanfacine—Hypersensitivity—Docetaxel—melanoma	0.000843	0.00188	CcSEcCtD
Guanfacine—Asthenia—Docetaxel—melanoma	0.000821	0.00183	CcSEcCtD
Guanfacine—Pruritus—Docetaxel—melanoma	0.00081	0.0018	CcSEcCtD
Guanfacine—Diarrhoea—Docetaxel—melanoma	0.000783	0.00174	CcSEcCtD
Guanfacine—Dizziness—Docetaxel—melanoma	0.000757	0.00169	CcSEcCtD
Guanfacine—Vomiting—Docetaxel—melanoma	0.000728	0.00162	CcSEcCtD
Guanfacine—Rash—Docetaxel—melanoma	0.000722	0.00161	CcSEcCtD
Guanfacine—Dermatitis—Docetaxel—melanoma	0.000721	0.00161	CcSEcCtD
Guanfacine—Headache—Docetaxel—melanoma	0.000717	0.0016	CcSEcCtD
Guanfacine—Nausea—Docetaxel—melanoma	0.00068	0.00151	CcSEcCtD
Guanfacine—CYP3A4—Metabolism—LUM—melanoma	5.24e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GNAQ—melanoma	5.24e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—TP53—melanoma	5.24e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CSF2—melanoma	5.23e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF1—melanoma	5.23e-05	0.000228	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—NRAS—melanoma	5.2e-05	0.000226	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.17e-05	0.000225	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—IL2—melanoma	5.16e-05	0.000224	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HPSE—melanoma	5.14e-05	0.000224	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—E2F1—melanoma	5.12e-05	0.000223	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CB—melanoma	5.1e-05	0.000222	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PDGFRA—melanoma	5.07e-05	0.000221	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP17A1—melanoma	5.06e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CG—melanoma	5.05e-05	0.00022	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CUBN—melanoma	5.04e-05	0.00022	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ITGB3—melanoma	5.02e-05	0.000218	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCA—melanoma	5.02e-05	0.000218	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—HRAS—melanoma	5.01e-05	0.000218	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.99e-05	0.000217	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.99e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK3—melanoma	4.98e-05	0.000217	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ABCB1—melanoma	4.95e-05	0.000215	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SYK—melanoma	4.93e-05	0.000214	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	4.92e-05	0.000214	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SPP1—melanoma	4.92e-05	0.000214	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAP2K2—melanoma	4.9e-05	0.000213	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CXCL8—melanoma	4.9e-05	0.000213	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CD—melanoma	4.89e-05	0.000213	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CSPG4—melanoma	4.87e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BSG—melanoma	4.87e-05	0.000212	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SDHD—melanoma	4.87e-05	0.000212	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ITGAV—melanoma	4.83e-05	0.00021	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT3—melanoma	4.83e-05	0.00021	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGFR—melanoma	4.83e-05	0.00021	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNA11—melanoma	4.77e-05	0.000208	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—MAPK1—melanoma	4.73e-05	0.000206	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPAM—melanoma	4.72e-05	0.000205	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL2—melanoma	4.68e-05	0.000204	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—FASN—melanoma	4.67e-05	0.000203	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TERT—melanoma	4.66e-05	0.000203	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RAC1—melanoma	4.65e-05	0.000202	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP17A1—melanoma	4.61e-05	0.000201	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC5A5—melanoma	4.6e-05	0.0002	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PRKCA—melanoma	4.55e-05	0.000198	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.55e-05	0.000198	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ERCC2—melanoma	4.51e-05	0.000197	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.49e-05	0.000195	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOCS1—melanoma	4.48e-05	0.000195	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—KRAS—melanoma	4.47e-05	0.000195	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAP2K1—melanoma	4.47e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—S100B—melanoma	4.47e-05	0.000194	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HIF1A—melanoma	4.46e-05	0.000194	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GNAQ—melanoma	4.44e-05	0.000193	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CD44—melanoma	4.44e-05	0.000193	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CD—melanoma	4.44e-05	0.000193	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—melanoma	4.42e-05	0.000193	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNA11—melanoma	4.35e-05	0.000189	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.35e-05	0.000189	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.31e-05	0.000187	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB4—melanoma	4.27e-05	0.000186	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—melanoma	4.27e-05	0.000186	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—FASN—melanoma	4.26e-05	0.000185	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CB—melanoma	4.26e-05	0.000185	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP1B1—melanoma	4.26e-05	0.000185	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN2B—melanoma	4.23e-05	0.000184	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC5A5—melanoma	4.19e-05	0.000182	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—PIK3CA—melanoma	4.11e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FN1—melanoma	4.11e-05	0.000179	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD86—melanoma	4.09e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CXCL8—melanoma	4.09e-05	0.000178	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EDN1—melanoma	4.06e-05	0.000177	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GNAQ—melanoma	4.05e-05	0.000176	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CD44—melanoma	4.05e-05	0.000176	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NOTCH1—melanoma	4.02e-05	0.000175	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLA2G6—melanoma	4.01e-05	0.000175	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—TP53—melanoma	3.97e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF1—melanoma	3.97e-05	0.000173	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CSF2—melanoma	3.97e-05	0.000173	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.96e-05	0.000172	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CD80—melanoma	3.94e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APC—melanoma	3.93e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KIT—melanoma	3.93e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CG—melanoma	3.93e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—NRAS—melanoma	3.93e-05	0.000171	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.93e-05	0.000171	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—IL2—melanoma	3.91e-05	0.00017	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—E2F1—melanoma	3.89e-05	0.000169	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGF—melanoma	3.88e-05	0.000169	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP1B1—melanoma	3.88e-05	0.000169	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CB—melanoma	3.87e-05	0.000168	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PDGFRA—melanoma	3.85e-05	0.000167	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ITGB3—melanoma	3.81e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCA—melanoma	3.81e-05	0.000166	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—HRAS—melanoma	3.8e-05	0.000165	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK3—melanoma	3.76e-05	0.000164	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.76e-05	0.000163	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SPP1—melanoma	3.73e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAP2K2—melanoma	3.72e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CXCL8—melanoma	3.72e-05	0.000162	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BRAF—melanoma	3.69e-05	0.000161	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—VCAN—melanoma	3.6e-05	0.000157	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IGF1—melanoma	3.6e-05	0.000157	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—MAPK1—melanoma	3.58e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—EGFR—melanoma	3.58e-05	0.000156	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CG—melanoma	3.57e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL2—melanoma	3.55e-05	0.000155	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TERT—melanoma	3.54e-05	0.000154	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RAC1—melanoma	3.53e-05	0.000154	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCB1—melanoma	3.5e-05	0.000153	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAP2K1—melanoma	3.48e-05	0.000151	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CD—melanoma	3.45e-05	0.00015	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PPARG—melanoma	3.44e-05	0.00015	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.42e-05	0.000149	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—PIK3CA—melanoma	3.42e-05	0.000149	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HIF1A—melanoma	3.38e-05	0.000147	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—KRAS—melanoma	3.38e-05	0.000147	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—melanoma	3.36e-05	0.000146	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF2—melanoma	3.31e-05	0.000144	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—melanoma	3.24e-05	0.000141	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PRKCA—melanoma	3.23e-05	0.00014	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ERCC2—melanoma	3.2e-05	0.000139	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCB1—melanoma	3.2e-05	0.000139	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CD—melanoma	3.13e-05	0.000136	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FN1—melanoma	3.12e-05	0.000136	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PIK3CA—melanoma	3.11e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MDM2—melanoma	3.09e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—melanoma	3.09e-05	0.000135	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ERBB2—melanoma	3.05e-05	0.000133	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NOTCH1—melanoma	3.05e-05	0.000133	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP17A1—melanoma	3.04e-05	0.000132	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CB—melanoma	3.01e-05	0.000131	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CD80—melanoma	2.99e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KIT—melanoma	2.98e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APC—melanoma	2.98e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CG—melanoma	2.98e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—NRAS—melanoma	2.98e-05	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGF—melanoma	2.95e-05	0.000128	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PRKCA—melanoma	2.94e-05	0.000128	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ERCC2—melanoma	2.92e-05	0.000127	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL8—melanoma	2.89e-05	0.000126	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—HRAS—melanoma	2.87e-05	0.000125	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNA11—melanoma	2.87e-05	0.000125	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK3—melanoma	2.86e-05	0.000124	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1B—melanoma	2.83e-05	0.000123	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—FASN—melanoma	2.81e-05	0.000122	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BRAF—melanoma	2.8e-05	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—melanoma	2.8e-05	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—melanoma	2.77e-05	0.000121	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL2—melanoma	2.77e-05	0.00012	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC5A5—melanoma	2.76e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6—melanoma	2.75e-05	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CB—melanoma	2.73e-05	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IGF1—melanoma	2.73e-05	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—MAPK1—melanoma	2.72e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—EGFR—melanoma	2.72e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—melanoma	2.71e-05	0.000118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCND1—melanoma	2.7e-05	0.000117	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CTNNB1—melanoma	2.67e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GNAQ—melanoma	2.67e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CD44—melanoma	2.67e-05	0.000116	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.65e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAP2K1—melanoma	2.64e-05	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CD—melanoma	2.62e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—melanoma	2.62e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDKN1A—melanoma	2.61e-05	0.000114	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTEN—melanoma	2.6e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	2.6e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NFKB1—melanoma	2.59e-05	0.000113	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—KRAS—melanoma	2.57e-05	0.000112	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP1B1—melanoma	2.56e-05	0.000111	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—melanoma	2.54e-05	0.00011	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CG—melanoma	2.53e-05	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF2—melanoma	2.51e-05	0.000109	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PPARG—melanoma	2.44e-05	0.000106	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.42e-05	0.000105	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTEN—melanoma	2.36e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	2.36e-05	0.000103	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—melanoma	2.35e-05	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MDM2—melanoma	2.35e-05	0.000102	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—STAT3—melanoma	2.33e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NRAS—melanoma	2.32e-05	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ERBB2—melanoma	2.32e-05	0.000101	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CG—melanoma	2.3e-05	0.0001	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	2.28e-05	9.94e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK3—melanoma	2.22e-05	9.68e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PPARG—melanoma	2.22e-05	9.68e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CD—melanoma	2.22e-05	9.67e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL8—melanoma	2.2e-05	9.56e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—melanoma	2.19e-05	9.54e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HRAS—melanoma	2.18e-05	9.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MYC—melanoma	2.16e-05	9.41e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	2.14e-05	9.33e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	2.12e-05	9.23e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MAPK1—melanoma	2.12e-05	9.21e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—EGFR—melanoma	2.11e-05	9.2e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCB1—melanoma	2.11e-05	9.17e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—melanoma	2.1e-05	9.15e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL2—melanoma	2.1e-05	9.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6—melanoma	2.09e-05	9.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCND1—melanoma	2.05e-05	8.9e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	2.03e-05	8.82e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CD—melanoma	2.02e-05	8.81e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—melanoma	2e-05	8.7e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KRAS—melanoma	2e-05	8.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—melanoma	1.99e-05	8.64e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	1.98e-05	8.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTEN—melanoma	1.97e-05	8.59e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NFKB1—melanoma	1.96e-05	8.55e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PRKCA—melanoma	1.94e-05	8.44e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CB—melanoma	1.94e-05	8.42e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—melanoma	1.93e-05	8.38e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ERCC2—melanoma	1.92e-05	8.37e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—melanoma	1.92e-05	8.35e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PIK3CA—melanoma	1.84e-05	7.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—melanoma	1.78e-05	7.76e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TP53—melanoma	1.78e-05	7.73e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—STAT3—melanoma	1.77e-05	7.68e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CB—melanoma	1.77e-05	7.68e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NRAS—melanoma	1.76e-05	7.67e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—melanoma	1.75e-05	7.61e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HRAS—melanoma	1.7e-05	7.39e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK3—melanoma	1.69e-05	7.34e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTEN—melanoma	1.67e-05	7.28e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PIK3CA—melanoma	1.67e-05	7.25e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MYC—melanoma	1.64e-05	7.14e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6—melanoma	1.63e-05	7.07e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MAPK1—melanoma	1.6e-05	6.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—EGFR—melanoma	1.6e-05	6.98e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTEN—melanoma	1.53e-05	6.64e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CG—melanoma	1.52e-05	6.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KRAS—melanoma	1.52e-05	6.6e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—melanoma	1.5e-05	6.53e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPARG—melanoma	1.47e-05	6.38e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	1.39e-05	6.06e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—melanoma	1.36e-05	5.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TP53—melanoma	1.35e-05	5.86e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CD—melanoma	1.34e-05	5.81e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—melanoma	1.32e-05	5.74e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HRAS—melanoma	1.29e-05	5.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6—melanoma	1.23e-05	5.37e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PIK3CA—melanoma	1.18e-05	5.14e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CB—melanoma	1.16e-05	5.07e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—melanoma	1.15e-05	5.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—melanoma	1.14e-05	4.95e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PIK3CA—melanoma	1.08e-05	4.68e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTEN—melanoma	1.01e-05	4.38e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—melanoma	9.64e-06	4.2e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—melanoma	8.79e-06	3.83e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PIK3CA—melanoma	7.1e-06	3.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—melanoma	5.8e-06	2.52e-05	CbGpPWpGaD
